Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07696273 · ClinicalTrials.gov registry record · NA
Miniaturized Breath-based Sensor for the Detection of Hypo- and Hyperglycemia
A NA study, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07696273 is a NA study that is actively recruiting participants, run by Indiana University. The registered enrollment target is 40 participants.
The verdict
NCT07696273, a NA study, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds (VOCs) in exhaled breath.
Interventions
- DEVICE Sensing Device and Tedlar Bags
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-05-31 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07696273
The ClinicalTrials.gov registry entry for NCT07696273 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sensing Device and Tedlar Bags is the first listed.
NCT07696273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07696273 about?
NCT07696273 is a clinical study titled "Miniaturized Breath-based Sensor for the Detection of Hypo- and Hyperglycemia". The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds (VOCs) in exhaled breath.
What is the current status of trial NCT07696273?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-05-31. Estimated completion is 2027-10-01.
What interventions are being tested in trial NCT07696273?
The interventions under investigation include: Sensing Device and Tedlar Bags (DEVICE).
Who is sponsoring clinical trial NCT07696273?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.